Functional characterization of the novelBRAFcomplex mutation,BRAFV600delinsYM, identified in papillary thyroid carcinoma-Reference-Cited by-同舟云学术

Functional characterization of the novelBRAFcomplex mutation,BRAFV600delinsYM, identified in papillary thyroid carcinoma

Published:2012-07-21 Issue:3 Volume:132 Page:738-743
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Matsuse Michiko,Mitsutake Norisato,Tanimura Susumu,Ogi Tomoo,Nishihara Eijun,Hirokawa Mitsuyoshi,Fuziwara Cesar S.,Saenko Vladimir A.,Suzuki Keiji,Miyauchi Akira,Yamashita Shunichi

Publisher

Wiley

Subject

Cancer Research,Oncology

Reference24 articles.

1. High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma;Kimura;Cancer Res,2003

2. BRAF mutations and RET/PTC rearrangements are alternative events in the etiopathogenesis of PTC;Soares;Oncogene,2003

3. Alternative mutations of BRAF, RET and NTRK1 are associated with similar but distinct gene expression patterns in papillary thyroid cancer;Frattini;Oncogene,2004

4. BRAF mutation in thyroid cancer;Xing;Endocr Relat Cancer,2005

5. BRAF mutations are associated with some histological types of papillary thyroid carcinoma;Trovisco;J Pathol,2004

Cited by 19 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Unveiling a rare BRAF mutation in minimally invasive follicular thyroid carcinoma: A case report;Medicine;2024-08-23

2. Dabrafenib for Pilocytic Astrocytoma With BRAF V599ins;JCO Precision Oncology;2024-05

3. Characterization of BRAF^Thr599dup Mutation as a Targetable Driver Mutation Identified in Lung Adenocarcinoma by Comprehensive Genomic Profiling;JCO Precision Oncology;2024-04

4. GA genotype of the Arg280His polymorphism on the XRCC1 gene: Genetic susceptibility genotype in differentiated thyroid carcinomas?;Balkan Journal of Medical Genetics;2021-06-01

5. Prolonged response to treatment based on cell-free DNA analysis and molecular profiling in three patients with metastatic cancer: a case series;Therapeutic Advances in Medical Oncology;2021-01